Learn more

KOREA CENTER DISEASE CONTROL & PREVENTION

Overview
  • Total Patents
    86
  • GoodIP Patent Rank
    16,903
  • Filing trend
    ⇧ 229.0%
About

KOREA CENTER DISEASE CONTROL & PREVENTION has a total of 86 patent applications. It increased the IP activity by 229.0%. Its first patent ever was published in 2012. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are LANZHOU VETERINARY RES INST CAAS, HARBIN VET RES INST CAAS and SHANGHAI VETERINARY RES INST CHINESE ACADEMY AGRICULTURAL SCIENCES CHINA CT ANIMAL.

Patent filings per year

Chart showing KOREA CENTER DISEASE CONTROL & PREVENTIONs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Gi Eun Rhie 11
#2 Mijung Ji 10
#3 Jeong Hoon Chun 10
#4 Yi Rang Hwang 10
#5 Byungki Cho 10
#6 Seolhye Hong 10
#7 Lee Won Ja 9
#8 Yang Jeong Sun 9
#9 Kang Chun 9
#10 Lee Joo Yeon 8

Latest patents

Publication Filing date Title
KR20200056351A Primer set for detecting yellow fever virus and uses thereof
KR20200056352A Primer set for detecting rift valley virus and uses thereof
KR20200056346A Primers and probes for simultaneous detection of subtypes of Ebola virus and detecting method for ebola virus using the same
KR20200056348A Primers and probes for simultaneous detection of subtypes of crimean-congo hemorrhagic fever virus and detecting method for crimean-congo hemorrhagic fever virus using the same
KR20200056349A Primers and probes for simultaneous detection of lineage of lassa virus and detecting method for lassa virus using the same
KR20200056347A Primers and probes for simultaneous detection of subtypes of Marburg virus and detecting method for Marburg virus using the same
KR102089268B1 A method for detecting hantaan virus using hantaan virus truncated nucleocapsid protein
KR20190118986A An antimicrobial management device using beacon in the our neighborhood
KR102059855B1 Recombinant adenovirus strain and vaccine composition against vivax malaria using the same
KR20200109998A Antibodies for neutralizing anthrax toxin and pharmaceutical composition comprising the same
KR20190128550A Primers for detection of direct acting antivirals-resistant gene of hepatitis c virus and detecting method of direct acting antivirals-resistant gene of hepatitis c virus using the same
KR20200107147A A composition for virus culture comprising a Janus kinase inhibitor and hexadimethrine bromide and a virus culture method using the same
KR20200101075A Composition for treating hepatitis B comprising inhibitor of HBV enhancer, ACK1
KR102019008B1 A method for detecting mers coronavirus using mers coronavirus nucleocapsid fusion protein
KR101969696B1 Monoclonal antibodies of specifically binding to spike S2 protein of MERS-CoV
KR20200076345A Attenuated vaccinia virus expressing Mycobacterium tuberculosis divalent antigen and vaccine for preventing Mycobacterium tuberculosis comprising the same
KR20200076335A Attenuated adeno virus expressing Mycobacterium tuberculosis multivalent antigen and vaccine for preventing Mycobacterium tuberculosis comprising the same
KR102005685B1 Recombinant vector of MERS-CoV expressing fluorescence protein derived from Korean MERS-CoV, and method of preparing the same
KR101966841B1 Recombinant antigen derived from zika virus e protein and use thereof
KR20200062858A Diagnostic test kit for diagnosing prediabetes and a method for diagnosing prediabetes